AVEO Pharmaceuticals (AVEO) Plans Stock Offering
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by AVEO.
The proposed size of the offering was note disclosed.
J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.
The proposed size of the offering was note disclosed.
J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MDA Space raises $819M in share offering to fund CLS acquisition
- AEON Biopharma prices $13.75M public offering with milestone warrants
- Spero Therapeutics secures $105M royalty-backed financing deal
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
JPMorgan, RBC Capital, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
